Chronic Pain, Opioids, and Anger Treatment
Unknown statusNot applicableNCT04438746
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The current US opioid epidemic is a pressing public health concern. Links between opioid misuse and mortality are well-known; nearly 70% of all drug overdose deaths in 2017 were attributable to opioids. Given their pain-relieving properties, opioids have been widely used in the chronic pain population who are also susceptible to misuse of these analgesics.. In chronic pain patients with anger, the pain as well as opioid use may be aggravated. For example, suppression of anger has been linked with increased pain sensitivity in experiments, while anger-hostility scores and internalized anger predict pain severity variance and pain intensity, respectively. Anger is also linked with drug use/abuse, including opioids. The goal of this research is to implement a state-of-the-art program for anger regulation in chronic pain patients., Called Cognitive Behavioral Affective Therapy (CBAT), this program is evaluated on multiple measures of anger, sensory versus affective measures of pain, and measures of opioid misuse. CBAT is expected to reduce anger, and thereby produce reduction in pain as well as shift attitudes away from opioid misuse..
Study details
- Official title
- Alleviating Pain and Opioid Dependence Through Anger Management: A Pilot Study
- Conditions
- Interventions
- Behavioral: Emotion discussion
- Behavioral: Cognitive Behavioral Affective Therapy
- Sponsor
- The University of Texas at San Antonio
- Start date
- 2020-07-01
- Primary completion
- 2022-01-01
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * taking opioid pain relievers for at least 3 months in the past 12 months * maladaptive levels of anger as measured by STAXI-2 * without psychiatric co-morbidity (e.g., major depression, substance use disorder, etc.) * not undergoing current psychological/psychiatric treatment * speak English. Exclusion Criteria: \-
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04438746